Skip to main content
. 2015 Oct 16;10(10):e0140036. doi: 10.1371/journal.pone.0140036

Table 1. DBA patient and healthy donor demographics.

Age Sex Ethnicity Gene Mutation Treatment Hb* (g/dL) Erythrocytes*(MIL/μL) MCV* (fL)
D1 32 F Caucasian RPS19, nonsense None 4.7, 10.4 1.1, 2.5 116, 119
D2 22 F Caucasian RPL5, splice site None 10.2, 10.6 3.1, 3.3 93, 93
D3 17 M Caucasian Unknown Prednisone 8.6, 7.0 2.3, 1.9 115, 117
D4 16 M Caucasian RPS19, splice site Prednisone 13.5, 14.3 4.2, 4.3 93, 96
D5 14 M Caucasian RPL11, frame shift Prednisone 11.5 3.7 98
D6 22 F Caucasian RPS17, frame shift Prednisone n.d, 14.6 n.d, 4.2 n.d, 98
C1 24 F Caucasian
C2 28 F Caucasian
C3 33 F Caucasian
C4 21 M Caucasian
C5 22 M Caucasian
C6 20 M Caucasian

*Two values were from separate blood draws at two different times that were used for the replicate proteome analyses designated as a and b, respectively

n.d—not determined.

Normal values for: Hb—13.5–17.5 males, 12.0–15.5 females; Erythrocytes—4.3–5.7 males, 3.9–5.0 females; mean corpuscular volume (MCV)—80–100 for male and female.

†Patients D1 and D2 were transfused in the past.